<?xml version='1.0' encoding='utf-8'?>
<document id="30737835"><sentence text="Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction study."><entity charOffset="11-21" id="DDI-PubMed.30737835.s1.e0" text="prednisone" /><entity charOffset="25-34" id="DDI-PubMed.30737835.s1.e1" text="docetaxel" /><pair ddi="false" e1="DDI-PubMed.30737835.s1.e0" e2="DDI-PubMed.30737835.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s1.e0" e2="DDI-PubMed.30737835.s1.e1" /></sentence><sentence text="Docetaxel has been approved for the treatment of metastatic prostate cancer in combination with prednisone"><entity charOffset="0-9" id="DDI-PubMed.30737835.s2.e0" text="Docetaxel" /><entity charOffset="96-106" id="DDI-PubMed.30737835.s2.e1" text="prednisone" /><pair ddi="false" e1="DDI-PubMed.30737835.s2.e0" e2="DDI-PubMed.30737835.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s2.e0" e2="DDI-PubMed.30737835.s2.e1" /></sentence><sentence text=" Since prednisone is known to induce the cytochrome P450 iso-enzyme CYP3A4, which is the main metabolizing enzyme of docetaxel in the liver, a potential drug-drug interaction may occur"><entity charOffset="7-17" id="DDI-PubMed.30737835.s3.e0" text="prednisone" /><entity charOffset="117-126" id="DDI-PubMed.30737835.s3.e1" text="docetaxel" /><pair ddi="false" e1="DDI-PubMed.30737835.s3.e0" e2="DDI-PubMed.30737835.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s3.e0" e2="DDI-PubMed.30737835.s3.e1" /></sentence><sentence text=" In this prospective randomized pharmacokinetic cross-over study we investigated docetaxel exposure with concomitant prednisone, compared to docetaxel monotherapy in men with metastatic prostate cancer"><entity charOffset="81-90" id="DDI-PubMed.30737835.s4.e0" text="docetaxel" /><entity charOffset="117-127" id="DDI-PubMed.30737835.s4.e1" text="prednisone" /><entity charOffset="141-150" id="DDI-PubMed.30737835.s4.e2" text="docetaxel" /><pair ddi="false" e1="DDI-PubMed.30737835.s4.e0" e2="DDI-PubMed.30737835.s4.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s4.e0" e2="DDI-PubMed.30737835.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s4.e0" e2="DDI-PubMed.30737835.s4.e2" /><pair ddi="false" e1="DDI-PubMed.30737835.s4.e1" e2="DDI-PubMed.30737835.s4.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s4.e1" e2="DDI-PubMed.30737835.s4.e2" /></sentence><sentence text="" /><sentence text="Patients scheduled to receive at least 6 cycles of docetaxel (75 mg/m2 ) and who gave written informed consent were randomized to receive either the 1st 3 cycles, or the last 3 consecutive cycles with prednisone (twice daily 5 mg)"><entity charOffset="51-60" id="DDI-PubMed.30737835.s6.e0" text="docetaxel" /><entity charOffset="201-211" id="DDI-PubMed.30737835.s6.e1" text="prednisone" /><pair ddi="false" e1="DDI-PubMed.30737835.s6.e0" e2="DDI-PubMed.30737835.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s6.e0" e2="DDI-PubMed.30737835.s6.e1" /></sentence><sentence text=" Pharmacokinetic blood sampling was performed during cycle 3 and cycle 6" /><sentence text=" Primary endpoint was difference in docetaxel exposure, calculated as area under the curve (AUC0-inf ) and analysed by means of a linear mixed model"><entity charOffset="36-45" id="DDI-PubMed.30737835.s8.e0" text="docetaxel" /></sentence><sentence text=" Given the cross-over design the study was powered on 18 patients to answer the primary, pharmacokinetic, endpoint" /><sentence text="" /><sentence text="Eighteen evaluable patients were included in the trial" /><sentence text=" Docetaxel concentration with concomitant prednisone (AUC0-inf 2784 ng*h/mL, 95% confidence interval 2436-3183 ng*h/mL) was similar to the concentration of docetaxel monotherapy (AUC0-inf 2647 ng*h/mL, 95% confidence interval 2377-2949 ng*h/mL)"><entity charOffset="1-10" id="DDI-PubMed.30737835.s12.e0" text="Docetaxel" /><entity charOffset="42-52" id="DDI-PubMed.30737835.s12.e1" text="prednisone" /><entity charOffset="156-165" id="DDI-PubMed.30737835.s12.e2" text="docetaxel" /><pair ddi="false" e1="DDI-PubMed.30737835.s12.e0" e2="DDI-PubMed.30737835.s12.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s12.e0" e2="DDI-PubMed.30737835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s12.e0" e2="DDI-PubMed.30737835.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30737835.s12.e1" e2="DDI-PubMed.30737835.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s12.e1" e2="DDI-PubMed.30737835.s12.e2" /></sentence><sentence text=" Exploratory analysis showed no toxicity differences between docetaxel monotherapy and docetaxel cycles with prednisone"><entity charOffset="61-70" id="DDI-PubMed.30737835.s13.e0" text="docetaxel" /><entity charOffset="87-96" id="DDI-PubMed.30737835.s13.e1" text="docetaxel" /><entity charOffset="109-119" id="DDI-PubMed.30737835.s13.e2" text="prednisone" /><pair ddi="false" e1="DDI-PubMed.30737835.s13.e0" e2="DDI-PubMed.30737835.s13.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s13.e0" e2="DDI-PubMed.30737835.s13.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s13.e0" e2="DDI-PubMed.30737835.s13.e2" /><pair ddi="false" e1="DDI-PubMed.30737835.s13.e1" e2="DDI-PubMed.30737835.s13.e1" /><pair ddi="false" e1="DDI-PubMed.30737835.s13.e1" e2="DDI-PubMed.30737835.s13.e2" /></sentence><sentence text="" /><sentence text="No significant difference in docetaxel concentrations was observed"><entity charOffset="29-38" id="DDI-PubMed.30737835.s15.e0" text="docetaxel" /></sentence><sentence text=" In addition, we found similar toxicity profiles in absence and presence of prednisone"><entity charOffset="76-86" id="DDI-PubMed.30737835.s16.e0" text="prednisone" /></sentence><sentence text=" Therefore, from a pharmacokinetic point of view, docetaxel may be administrated with or without prednisone"><entity charOffset="50-59" id="DDI-PubMed.30737835.s17.e0" text="docetaxel" /><entity charOffset="97-107" id="DDI-PubMed.30737835.s17.e1" text="prednisone" /><pair ddi="false" e1="DDI-PubMed.30737835.s17.e0" e2="DDI-PubMed.30737835.s17.e0" /><pair ddi="false" e1="DDI-PubMed.30737835.s17.e0" e2="DDI-PubMed.30737835.s17.e1" /></sentence><sentence text="" /></document>